Kimme Hyrich to Morbidity
This is a "connection" page, showing publications Kimme Hyrich has written about Morbidity.
Connection Strength
0.148
-
Serious infection risk after 1 year between patients with rheumatoid arthritis treated with rituximab or with a second TNFi after initial TNFi failure: results from The British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Rheumatology (Oxford). 2018 09 01; 57(9):1533-1540.
Score: 0.116
-
The predictors of and reasons for non-adherence in an observational cohort of patients with rheumatoid arthritis commencing methotrexate. Rheumatology (Oxford). 2020 01 01; 59(1):213-223.
Score: 0.032